Has a product placement enticement or whatever been thought to be there? Somehow that's all part of their marketing budget.
In order for you to be able to do a non-patent medicine review process as you do for brand names, do you feel that you need to be able to look at the books of generic companies? My personal opinion is that if we're going to spend all of these public dollars on drugs, if we're going to buy stuff from them, in terms of whether it's first nations, whether it's all of these things, shouldn't we as parliamentarians be able to see their books? I would like to know how much profit there is, in terms of being able to review whether we're spending taxpayers' money in an accountable way.